The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable buzz within the healthcare community. This groundbreaking dual GIP and GLP-1 receptor medication seems to provide notable improvements in weight reduction compared to previous therapies. Early clinical studies have demonstrated significant decreases in body fat percen